Pharmacoeconomics of intravenous immunoglobulin in various neurological disorders
Tsai, C.-P.
Acta Neurologica Taiwanica 19(4): 303-308
2010
ISSN/ISBN: 1028-768X PMID: 21234830 Document Number: 640066
Document emailed within 1 workday
Related Documents
Wintzell, A.; Eriksson, T.; Lundgren, A.; Petersson, J. 2008: Treatment with intravenous immunoglobulin in neurological diseases. a descriptive study of effects seen from the patient's and health services' perspectives Lakartidningen 105(21): 1571-1575Komoly, S.ám. 2014: Intravenous immunoglobulin therapy in neuroimmunological disorders Ideggyogyaszati Szemle 67(7-8): 281-282
Blanchette, V.S.; Kirby, M.A.; Turner, C. 1992: Role of intravenous immunoglobulin G in autoimmune hematologic disorders Seminars in Hematology 29(3 Suppl 2: 72-82
Börner, P.; Deicher, H.; Bähr, I.; Chalius, H.H.; Ghani, G.; Geldmacher, H.; Henke, I.W.; Kindermann, L.; Marks, V. 1976: Prophylatic rhesus sensitization via intravenous administration of immunoglobulin G anti-D. III. Limits of the prophylaxsis obtainable by adapting the immunoglobulin dosage to the extent of the fetalmaternal blood transfusion Geburtshilfe und Frauenheilkunde 36(6): 485-492
Noya, M.; Castillo, J.; Lema, M.; Alvarez-Prechous, A.; Prieto, A. 1976: Measurement of immunoglobulin G in cerebrospinal fluid in different neurological processes Revista Clinica Espanola 141(5): 421-425
Nakada, T. 2016: Intravenous immunoglobulin therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 74(Suppl 6): 527-531
Ventura, A.; Florean, P.; Pascone, R.; Perini, R.; Pocecco, M.; Lepore, L. 1986: Intravenous immunoglobulin in immune neutropenia Helvetica Paediatrica Acta 41(6): 495-500
Rault, R.; Piraino, B.; Johnston, J.R.; Oral, A. 1991: Pulmonary and renal toxicity of intravenous immunoglobulin Clinical Nephrology 36(2): 83-86
Rüfenacht, R.; Morell 1991: Immunochemical characterization of intravenous immunoglobulin preparations Allergologia et Immunopathologia 19(5): 197-200
Walsh, J.J. 1974: Studies on the purification of normal immunoglobulin for intravenous use Developments in Biological Standardization 27: 31-36
Gadoth, N.; Melamed, E.; Miller, A.; Steiner, I.; Abramsky, O. 1999: Intravenous immunoglobulin treatment in multiple sclerosis Neurology 52(1): 214-215
Llombart, M.; García-Abujeta, J.L.; Sánchez-Pérez, R.M.; Hernando de Larramendi, C. 2007: Pompholyx induced by intravenous immunoglobulin therapy Journal of Investigational Allergology and Clinical Immunology 17(4): 277-278
Taneichi, H.; Miyawaki, T. 2011: High-dose intravenous immunoglobulin treatment Nihon Rinsho. Japanese Journal of Clinical Medicine 69(3): 515-519
Lucas, G.S.; Jobbins, K.; Bloom, A.L. 1987: Intravenous immunoglobulin and blood group antibodies Lancet 2(8561): 742
Tuohy, P.G. 1992: Intravenous immunoglobulin in chronic relapsing polyneuropathy New Zealand Medical Journal 105(928): 60-61
Ishii, N.; Hashimoto, T. 2010: Intravenous immunoglobulin (TVIG) therapy in pemphigus Nihon Rinsho. Japanese Journal of Clinical Medicine 68(11): 2143-2146
Nydegger, U.E. 1983: Evaluation criteria for intravenous immunoglobulin G preparations Presse Medicale 12(41): 2619-2624
Guencheva, G. 1984: Requirements and characteristics of various immunoglobulin preparations for intravenous application Zeitschrift für die Gesamte Hygiene und ihre Grenzgebiete 30(1): 21-23
Lever, A.M.; Webster, A.D.; Brown, D.; Thomas, H.C. 1984: Non-A, non-B hepatitis occurring in agammaglobulinaemic patients after intravenous immunoglobulin Lancet 2(8411): 1062-1064
Korsak, J.; Zaleska, B.; Orłowska, E.; Kotowicz, J. 2005: Use of high dose intravenous immunoglobulin in neurologic disease Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 19(109): 98-101